Nexentis Technologies Inc (NXTS) Stock Price, Quote & News

Company Profile

Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and...

Industry: Agricultural Inputs

Sector: Basic Materials

Phone: 972 347 468 9583

Website: www.nexentistech.com

Address:

Pinhas Sapir St. 3, Kiryat HaMada, Ness Ziona, Israel

SugarKitty Jul. 29 at 8:38 PM

$DFNS $WSHP $FXHO $BATL $NXTS told you envious mofos…watch him…match him…eat for years…

0 · Reply

Paraboljoker Jul. 29 at 7:43 PM

$DFNS everything u wanted at $7 $WSHP $FXHO $BATL $NXTS loading before 5x which goes first?🫴🔮

1 · Reply

Paraboljoker Jul. 29 at 7:37 PM

$DFNS everything u wanted at $7 $WSHP $FXHO $BATL $NXTS loading before gonzo

0 · Reply

Robere Jul. 28 at 12:08 PM

$NXTS news

0 · Reply

Stock_Catcher Jul. 28 at 12:06 PM

$NXTS Hourly Bounce

0 · Reply

ExploringTrades Jul. 23 at 10:00 PM

$PRZO $NXTS Long

0 · Reply

clostov1919 Jul. 22 at 2:20 PM

$NXTS another RS coming

0 · Reply

ScanStock Jul. 20 at 11:38 PM

$NXTS NIto ?

0 · Reply

HUBIE_DUBOIS Jul. 14 at 6:47 PM

$NXTS Cutting my loss here. Hope it goes up for all still holding.

1 · Reply

HUBIE_DUBOIS Jul. 14 at 2:31 PM

$NXTS I would venture to say that with last nights filing that says they can/will sell up to $100 million in stock, that this stock is done for. My guess they are just going to dilute this thing to nothing. Not shocked as it's an Israeli company and they are now just as bad as the Asian companies.

1 · Reply

Nexentis Technologies Subsidiary MitoCareX Bio Selects Transport Protein Candidate for Drug Discovery Campaign

2026-07-13T20:10:49.000Z - 16 days ago

Nexentis Technologies registers to sell 2.57M shares of common stock for holders

Jul 7, 2026, 8:25 AM EDT - 22 days ago

Nexentis Subsidiary MitoCareX Bio Advances SLC Transporter Drug Discovery with Broad Analysis and International AI Initiative

2026-06-29T12:45:25.000Z - 4 weeks ago

Nexentis Technologies announces monetization of Melz solar investment

Jun 29, 2026, 8:20 AM EDT - 4 weeks ago

Nexentis Announces Monetization of Part of its Melz Solar Investment at $14.5 Million Project Valuation – Significant Premium to Initial Investment

2026-06-22T14:07:09.000Z - 5 weeks ago

Nexentis Technologies Inc trading halted, volatility trading pause

2026-06-22T14:02:47.000Z - 5 weeks ago

Nexentis Technologies Inc trading resumes

Jun 22, 2026, 8:22 AM EDT - 5 weeks ago

Nexentis Technologies Announces International AI Drug Discovery Initiative Between MitoCareX Bio and Boltz to Accelerate Novel SLC Small-Molecule Discovery

Jun 17, 2026, 7:32 AM EDT - 6 weeks ago

Nexentis: Subsidiary MitoCareX Bio Successfully Completed Broad Analysis of SLC Transport Proteins to Support Discovery of Hard-to-Treat Cancers and Metabolic Diseases

2026-06-16T19:50:41.000Z - 6 weeks ago

Nexentis Technologies Inc trading resumes

2026-06-16T19:40:09.000Z - 6 weeks ago

Nexentis Technologies Inc trading halted, volatility trading pause

2026-05-18T13:36:00.000Z - 2 months ago

Nexentis Technologies says MitoCareX Bio achieves drug discovery milestone

May 18, 2026, 9:30 AM EDT - 2 months ago

Nexentis Announces MitoCareX Bio Achieves Key R&D Milestone, Generating a Substantially Improved Hit Molecule on the Path to Pre-Clinical Development

May 13, 2026, 7:07 AM EDT - 2 months ago

Nexentis Technologies Announces Optimization of Hit Molecule at MitoCareX Bio Representing Key Drug Discovery Milestone

2026-05-08T14:05:30.000Z - 2 months ago

Nexentis Technologies Inc trading halted, volatility trading pause

2026-05-08T13:54:38.000Z - 2 months ago

Nexentis Technologies Inc trading resumes

2026-05-05T13:20:28.000Z - 3 months ago

Nexentis Technologies announces Mitoline U.S. trademark registration approval

May 5, 2026, 7:32 AM EDT - 3 months ago

Nexentis Technologies Announces U.S. Trademark Registration Approval for MitoCareX's Algorithm Platform MITOLINE™

2026-04-16T20:21:32.000Z - 3 months ago

Nexentis Technologies files $100M mixed securities shelf

2026-04-07T23:51:14.000Z - 4 months ago

Nexentis Technologies Inc trading halted, news pending

2026-03-13T13:21:15.000Z - 4 months ago

Nexentis Technologies launches new corporate website

Feb 19, 2026, 3:20 PM EST - 5 months ago

N2OFF, Inc. Provides Early Warning Disclosure

Feb 2, 2026, 8:05 AM EST - 6 months ago

In Spaceflight Conditions: N2OFF‘s MitoCareX Bio Highlights Co-Founder's Innovative Research on Mitochondrial Carriers in Microgravity and Cosmic radiation Conditions

Jan 22, 2026, 7:32 AM EST - 6 months ago

N2OFF: MitoCareX Bio Announces Positive In Vitro Results from Its Mitochondrial Carrier Small Molecule Platform

Jan 15, 2026, 8:32 AM EST - 6 months ago

N2OFF: MitoCareX Bio Spotlights Co-Founder's Pioneering Research on Mitochondrial Carriers in Spaceflight Stress Conditions

Jan 5, 2026, 9:20 AM EST - 7 months ago

N2OFF Advances $340,000 Payment to Gain Better Terms in Flag Solar Energy Initiative, Reflecting Approximately an Additional $1.7 Million in Project Profit Stake

Dec 29, 2025, 8:22 AM EST - 7 months ago

N2OFF Accelerates European Renewable Energy Momentum with Major De-Risking Milestones and Approximately $1.69 Million Value Unlock in Germany and Italy

Nov 18, 2025, 9:12 AM EST - 9 months ago

N2OFF: MitoCareX Identifies Hit Compounds and Targets Preclinical Candidate Nomination

Oct 30, 2025, 9:25 AM EDT - 9 months ago

N2OFF Completed Merger with Cancer Drug Discovery Company Targeting Tough-to-Treat Pancreatic and Lung Cancers

Oct 23, 2025, 8:25 AM EDT - 9 months ago

N2OFF Announces Closing of Merger with Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer

Sep 25, 2025, 4:01 PM EDT - 10 months ago

N2OFF Stockholders Approve Merger with Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer

Sep 18, 2025, 7:50 AM EDT - 11 months ago

N2OFF Provides Business Update on Successful Execution of Solar and Energy Storage Initiatives Across Europe

Sep 11, 2025, 7:42 AM EDT - 11 months ago

N2OFF to Expand its Melz Solar Project with Battery Storage

Jul 11, 2025, 8:40 AM EDT - 1 year ago

N2OFF Completes $1.2 million of its $2.7 million Total Commitment to Finance 196MWp Battery Energy Storage Assets in Italy

Jun 16, 2025, 8:10 AM EDT - 1 year ago

N2OFF is Increasing its Investment in Melz Project to Explore Additional 40-60 MW Battery Storage

May 15, 2025, 7:32 AM EDT - 1 year ago

N2OFF Energy Targets European's Energy Crises with Fourth Regional Battery Project

May 9, 2025, 7:45 AM EDT - 1 year ago

N2OFF via Solterra Expands European Footprint with Entry into Fourth Project – a Battery Storage Venture in Poland

Apr 8, 2025, 6:04 AM EDT - 1 year ago

N2OFF Announces Potential to Maximize Investment Opportunity Following New Regulation in Germany

Mar 18, 2025, 6:33 AM EDT - 1 year ago

N2OFF Signs Non-Binding LOI for Potential 380MW Battery Energy Storage Projects

Mar 5, 2025, 6:10 AM EST - 1 year ago

N2OFF Secures Definitive Agreement to Commercialize 196 MWp Battery Storage Projects

Mar 3, 2025, 8:45 AM EST - 1 year ago

N2OFF Establishes a US Subsidiary for Its Solar PV Operations

Feb 26, 2025, 9:29 AM EST - 1 year ago

N2OFF Signs Definitive Agreement to Acquire Next-Gen Computational Drug Discovery Company, Targeting Hard To Treat Cancers

Feb 24, 2025, 8:40 AM EST - 1 year ago

N2OFF and Solterra Announce the Closing of a Definitive Agreement to Develop 196 MWp Battery Storage Projects in Italy

Feb 10, 2025, 9:15 AM EST - 1 year ago

N2OFF and Solterra Unite to Pioneer Solar PV Development in Albania

Jan 23, 2025, 9:08 AM EST - 1 year ago

N2OFF and Solterra Join Forces to Exclusively Co-Develop the Solar PV Market in Albania

Jan 15, 2025, 8:25 AM EST - 1 year ago

N2OFF: Save Foods Ltd. (100%) Wins Patent Opposition Filed by ECOLAB in Europe

Jan 13, 2025, 8:52 AM EST - 1 year ago

N2OFF, Inc. Announces 111 MWp Solar PV Project in Germany Secures Regulatory Approval

Jan 8, 2025, 6:00 AM EST - 1 year ago

N2OFF Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

Jan 3, 2025, 7:55 AM EST - 1 year ago

N2OFF and Solterra Brand Services Italy executed a binding LOI to Develop Two 98MWp Battery Storage Projects in Sicily

Jan 2, 2025, 8:05 AM EST - 1 year ago

N2OFF, Inc. Announces Its JV with Soltera Renewable Energy Ltd Obtained an Approval of 111 MWp Solar PV Project in Meltz Germany

Oct 8, 2024, 9:29 AM EDT - 1 year ago

N2OFF Announces Letter of Intent with Ethiopian Federal Agency to Mandate Large-Scale Farmers to Utilize Save Foods' Eco-Friendly Solutions

Sep 30, 2024, 4:06 PM EDT - 1 year ago

N2OFF Inc. and Solterra Unlock New Potential for Capacity Expansion in Solar PV Project

Sep 18, 2024, 9:28 AM EDT - 2 years ago

N2OFF, Inc: Solterra Advances JV Solar PV Project Following Key Zoning Submission in Melz, Germany

Sep 11, 2024, 4:05 PM EDT - 2 years ago

N2OFF Inc. and Solterra Announce Potential to Increase Capacity in Solar PV Joint Venture Project

Aug 27, 2024, 9:13 AM EDT - 2 years ago

N2OFF Inc. Solar PV JV Secures Approval to Connect First PV Solar Project in Germany to the Power Grid of a Regional Energy Provider

Aug 21, 2024, 4:21 PM EDT - 2 years ago

N2OFF Inc Joins the EU PV Market: Investing in 111 MW Project in Germany

Aug 20, 2024, 4:04 PM EDT - 2 years ago

N2OFF INC. to Pursue Food Waste Carbon Credit Verra VM00046 Methodology

Jul 31, 2024, 9:04 AM EDT - 2 years ago

N2OFF, INC. Entered into an Agreement to Fund up to € 8 million for 50% Rights in Several Solar PV Projects to be Developed by Solterra Renewable Energy Ltd.

Jul 22, 2024, 9:25 AM EDT - 2 years ago

N2OFF INC. Enters the Growing Solar PV Market and signs an Agreement with a Company of Seasoned Experts in the Field

Jun 25, 2024, 8:05 AM EDT - 2 years ago

N2OFFAnnounces Breakthrough in Reducing N₂O Emissions with Innovative Bacterial Technology in Corn Cultivation

Jun 17, 2024, 8:28 AM EDT - 2 years ago

N2OFF: Save Foods is Expanding in Latin America with New Purchase Order from a Peruvian Customer

May 28, 2024, 8:28 AM EDT - 2 years ago

N2OFF: Save Foods' Innovative Technology Secures Patent Approval in South Africa, Strengthening Global Food Safety Efforts

May 9, 2024, 9:18 AM EDT - 2 years ago

NTWO OFF Achieved Positive Results of Over 22% improvement in Reduction of N2O Emissions in Open Greenhouse Environment

SugarKitty Jul. 29 at 8:38 PM

$DFNS $WSHP $FXHO $BATL $NXTS told you envious mofos…watch him…match him…eat for years…

0 · Reply

Paraboljoker Jul. 29 at 7:43 PM

$DFNS everything u wanted at $7 $WSHP $FXHO $BATL $NXTS loading before 5x which goes first?🫴🔮

1 · Reply

Paraboljoker Jul. 29 at 7:37 PM

$DFNS everything u wanted at $7 $WSHP $FXHO $BATL $NXTS loading before gonzo

0 · Reply

Robere Jul. 28 at 12:08 PM

$NXTS news

0 · Reply

Stock_Catcher Jul. 28 at 12:06 PM

$NXTS Hourly Bounce

0 · Reply

ExploringTrades Jul. 23 at 10:00 PM

$PRZO $NXTS Long

0 · Reply

clostov1919 Jul. 22 at 2:20 PM

$NXTS another RS coming

0 · Reply

ScanStock Jul. 20 at 11:38 PM

$NXTS NIto ?

0 · Reply

HUBIE_DUBOIS Jul. 14 at 6:47 PM

$NXTS Cutting my loss here. Hope it goes up for all still holding.

1 · Reply

HUBIE_DUBOIS Jul. 14 at 2:31 PM

1 · Reply

CTNODBIC Jul. 13 at 7:51 PM

$NXTS we did receive good news 3 weeks ago before the pump and crash???

0 · Reply

windough Jul. 12 at 8:37 PM

$NXTS I still expect a double the solar biz has got to be worth way more then just a yr ago and the bio tech stuff seems to be taking off

0 · Reply

Sw1ngb0t Jul. 9 at 1:07 AM

$NXTS this going big? we'll see

0 · Reply

windough Jul. 7 at 7:42 PM

$NXTS take the PR and run it through GROK and see what it means, could be

0 · Reply

HUBIE_DUBOIS Jul. 7 at 3:59 PM

$NXTS Getting some movement. Come on, run this thing!!!!!

0 · Reply

HUBIE_DUBOIS Jul. 7 at 1:58 PM

$NXTS 52 week low and looking like it will drop a lot more

0 · Reply

GSP Jul. 7 at 12:27 PM

$NXTS 1.4m float - Nexentis Subsidiary MitoCareX Bio Advances SLC Transporter Drug Discovery with Broad Analysis and International AI Initiative

0 · Reply

Stock_Catcher Jul. 7 at 12:25 PM

$NXTS Nexentis Subsidiary MitoCareX Bio Advances SLC Transporter Drug Discovery with Broad Analysis and International AI Initiative

0 · Reply

windough Jul. 6 at 9:20 PM

$NXTS still looking for a double

0 · Reply

Market Cap	2.25M
Revenue (ttm)	0.00
Net Income (ttm)	-4.00M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.04

Volume	49,900
Avg Vol	1,626,950
Day's Range	N/A - N/A
Shares Out	1.45M
Stochastic %K	5%
Beta	1.80
Analysts	Strong Buy
Price Target	N/A